These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 9169576

  • 41. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M, Moriya M, Nojo T.
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [Abstract] [Full Text] [Related]

  • 42. Age and regional cerebral blood flow in schizophrenia: age effects in anterior cingulate, frontal, and parietal cortex.
    Schultz SK, O'Leary DS, Boles Ponto LL, Arndt S, Magnotta V, Watkins GL, Hichwa RD, Andreasen NC.
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):19-24. PubMed ID: 11884650
    [Abstract] [Full Text] [Related]

  • 43. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW, Yoon HJ, Kang DY, Kim BC, Kim S, Kim JW.
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [Abstract] [Full Text] [Related]

  • 44. 3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease.
    Zou JX, Wang MJ, Lei XJ, Chen XG.
    Exp Gerontol; 2014 Dec; 60():31-6. PubMed ID: 25220149
    [Abstract] [Full Text] [Related]

  • 45. Regional cerebral perfusion alterations in patients with mild cognitive impairment and Alzheimer disease using dynamic susceptibility contrast MRI.
    Hauser T, Schönknecht P, Thomann PA, Gerigk L, Schröder J, Henze R, Radbruch A, Essig M.
    Acad Radiol; 2013 Jun; 20(6):705-11. PubMed ID: 23664398
    [Abstract] [Full Text] [Related]

  • 46. Trail making test B and brain perfusion imaging in mild cognitive impairment and mild Alzheimer's disease.
    Terada S, Sato S, Nagao S, Ikeda C, Shindo A, Hayashi S, Oshima E, Yokota O, Uchitomi Y.
    Psychiatry Res; 2013 Sep 30; 213(3):249-55. PubMed ID: 23830931
    [Abstract] [Full Text] [Related]

  • 47. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A, Pappatà S, Caracò C, Soricelli A, Milan G, Quarantelli M, Alfano B, Postiglione A, Salvatore M.
    Eur J Nucl Med Mol Imaging; 2002 Nov 30; 29(11):1447-54. PubMed ID: 12397463
    [Abstract] [Full Text] [Related]

  • 48. Posterior Associative and Cingulate Cortex Involvement of Brain Single-Photon Emission Computed Tomography (SPECT) Imaging in Semantic Dementia with Probable Alzheimer Disease Pathology: A Case Report.
    Takano Y, Kunitoki K, Tatewaki Y, Mutoh T, Totsune T, Shimomura H, Nakagawa M, Arai H, Taki Y.
    Am J Case Rep; 2018 Feb 12; 19():153-157. PubMed ID: 29429985
    [Abstract] [Full Text] [Related]

  • 49. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
    Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE.
    Ann Neurol; 1997 Jul 12; 42(1):85-94. PubMed ID: 9225689
    [Abstract] [Full Text] [Related]

  • 50. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J.
    Psychiatry Res; 2007 Jul 15; 155(2):147-54. PubMed ID: 17524628
    [Abstract] [Full Text] [Related]

  • 51. Evaluation of regional cerebral blood flow in Alzheimer's disease patients with subclinical hypothyroidism.
    Haji M, Kimura N, Hanaoka T, Aso Y, Takemaru M, Hirano T, Matsubara E.
    Dement Geriatr Cogn Disord; 2015 Jul 15; 39(5-6):360-7. PubMed ID: 25895684
    [Abstract] [Full Text] [Related]

  • 52. Different post label delay cerebral blood flow measurements in patients with Alzheimer's disease using 3D arterial spin labeling.
    Liu Y, Zeng X, Wang Z, Zhang N, Fan D, Yuan H.
    Magn Reson Imaging; 2015 Nov 15; 33(9):1019-1025. PubMed ID: 26113261
    [Abstract] [Full Text] [Related]

  • 53. Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
    Imabayashi E, Soma T, Sone D, Tsukamoto T, Kimura Y, Sato N, Murata M, Matsuda H.
    Ann Nucl Med; 2017 Aug 15; 31(7):536-543. PubMed ID: 28547521
    [Abstract] [Full Text] [Related]

  • 54. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.
    Kerrouche N, Herholz K, Mielke R, Holthoff V, Baron JC.
    J Cereb Blood Flow Metab; 2006 Sep 15; 26(9):1213-21. PubMed ID: 16525414
    [Abstract] [Full Text] [Related]

  • 55. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD.
    Eur J Nucl Med; 1994 Oct 15; 21(10):1052-60. PubMed ID: 7828614
    [Abstract] [Full Text] [Related]

  • 56. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.
    Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.
    Eur J Nucl Med Mol Imaging; 2003 Aug 15; 30(8):1104-13. PubMed ID: 12764551
    [Abstract] [Full Text] [Related]

  • 57. Combination of MRI hippocampal volumetry and arterial spin labeling MR perfusion at 3-Tesla improves the efficacy in discriminating Alzheimer's disease from cognitively normal elderly adults.
    Mak HK, Qian W, Ng KS, Chan Q, Song YQ, Chu LW, Yau KK.
    J Alzheimers Dis; 2014 Aug 15; 41(3):749-58. PubMed ID: 24670395
    [Abstract] [Full Text] [Related]

  • 58. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
    Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M.
    J Alzheimers Dis; 2011 Aug 15; 27(3):591-601. PubMed ID: 21841260
    [Abstract] [Full Text] [Related]

  • 59. Regional cerebral blood flow reductions, heart failure and Alzheimer's disease.
    Alves TC, Busatto GF.
    Neurol Res; 2006 Sep 15; 28(6):579-87. PubMed ID: 16945208
    [Abstract] [Full Text] [Related]

  • 60. Relatively preserved hippocampal glucose metabolism in mild Alzheimer's disease.
    Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E.
    Dement Geriatr Cogn Disord; 1998 Sep 15; 9(6):317-22. PubMed ID: 9769444
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.